South America Kidney Cancer Therapeutics & Diagnostics Market Analysis
The South America Kidney Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 6.5% during the forecast period.
Kidney cancer is a disease that starts in the kidneys. It happens when healthy cells in one or both kidneys grow out of control and form a tumor. Renal cell carcinoma is the most common type of kidney cancer found in adults.
In South America, the cases of kidney cancer are on the rise. This has resulted in increasing demand for kidney therapeutics and diagnostics. Currently, there are various treatment options available and many drugs are in pipeline too, which is expected to drive the kidney cancer therapeutics and diagnostics market during the forecast period.
In addition, rising investments in research by various government bodies and the development of novel drugs by pharmaceutical and biotechnology companies are other major contributing factors. Hence all these factors are expected to help the growth of kidney cancer and therapeutics market in South America.
South America Kidney Cancer Therapeutics & Diagnostics Market Trends
Application in Renal Cell Carcinoma is expected to Dominate the Market
Renal cell carcinoma is the most common type of adult kidney cancer, making up about 85% of diagnoses. This type of cancer develops in the proximal renal tubules that make up the kidney’s filtration system. There are thousands of these tiny filtration units in each kidney.
In South America, the prevalence of kidney cancer is expected to rise as per the estimates by the International Agency for Research on Cancer 2018 data. As renal cell carcinoma is most common type of cancer, the demand for its therapeutics and diagnostics is expected to rise as well. In addition, there are also other factors that are driving the market that includes growing awareness among people about cancer, the increased diagnostic rates, rising geriatric population, and rising incidence of renal cancer.
South America Kidney Cancer Therapeutics & Diagnostics Industry Overview
South America is a developing region. Although the healthcare system in many countries in the region are not highly developed, these countries are spending more each year in their healthcare system. This has encouraged many global companies to enter the market and as a result, many global players in the patient monitoring market are present in the region. These factors have made the region very competitive.
South America Kidney Cancer Therapeutics & Diagnostics Market Leaders
Eisai
Bristol Myers Squibb Company
Exelixis
Novartis International AG
Bayer AG
- *Disclaimer: Major Players sorted in no particular order
